Finanzwire Finanzwire
Basculer en Français
10649 Companies
226529 Keywords
155014 Articles
119928 Press releases
Headlines Articles Press releases Americord Remove
  1. Home
  2. Companies
  3. Americord
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/23/2024 at 16:30, 2 years 4 months ago

    Americord makes breakthrough in treating Motor Neuron Disease with cord blood stem cells

    Americord Stem Cells Cord Blood Motor Neuron Disease Treatment
  • PRESS RELEASE

    published on 02/23/2024 at 16:30, 2 years 4 months ago

    Americord Releases Cord Blood Stem Cells for Treatment of Motor Neuron Disease

    Americord releases cord blood stem cells for the treatment of motor neuron disease in India, highlighting the therapeutic potential of stem cells in healthcare
    Healthcare Americord Motor Neuron Disease Treatment Cord Blood Stem Cells
    Logo of Americord
  • PRESS RELEASE

    published on 12/06/2023 at 15:00, 2 years 6 months ago

    Americord Elevates Standards With Strategic Lab Relocation to Somerset, New Jersey

    Americord, a leader in the biobanking industry, has relocated its laboratory from New York City to a state-of-the-art facility in Somerset, New Jersey, marking a milestone in advancing research, product quality, and growth opportunities
    Americord Biobanking Laboratory Relocation Research Somerset New Jersey
    Logo of Americord
Accesswire
  • Published on 06/26/2026 at 23:00, 15 minutes ago

    Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting

  • Published on 06/26/2026 at 22:50, 25 minutes ago

    Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada

  • Published on 06/26/2026 at 22:15, 1 hour ago

    Revive Therapeutics Announces Proposed Private Placement

  • Published on 06/26/2026 at 15:05, 8 hours 10 minutes ago

    Vox Royalty Sells I-80 Gold Offtake Stream

  • Published on 06/26/2026 at 14:05, 9 hours 10 minutes ago

    SouthGobi Announces Voting Results of Annual General Meeting of Shareholders

View all ACCESSWIRE
EQS Group
  • Published on 06/26/2026 at 23:05, 10 minutes ago

    CASEKOO Goes GRS: Certified Greener, Built Bolder

  • Published on 06/26/2026 at 19:50, 3 hours 25 minutes ago

    Name Change Completed for C Capital's Swiss Listed Entity, Ticker Symbol CCAP Goes Live

  • Published on 06/26/2026 at 19:10, 4 hours 5 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 06/26/2026 at 18:04, 5 hours 11 minutes ago

    Turkiye Garanti Bankasi A.S.: Bond, subordinated debts, that can be included in the equity calculation debt instrument issuance CMB Application

  • Published on 06/26/2026 at 18:00, 5 hours 15 minutes ago

    PSP Swiss Property has sold the Richtipark in Wallisellen. The EBITDA guidance for the 2026 financial year has been increased.

View all EQS
Les Echos
  • Published on 06/26/2026 at 17:45, 5 hours 30 minutes ago

    Combined General Meeting, June 25, 2026

  • Published on 06/26/2026 at 14:44, 8 hours 31 minutes ago

    Safran information

  • Published on 06/26/2026 at 07:00, 16 hours 15 minutes ago

    Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel

  • Published on 06/25/2026 at 17:50, 1 day 5 hours ago

    DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 06/25/2026 at 07:30, 1 day 15 hours ago

    Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy